REFERENCES
- Smith JP. Treatment of chronic hepatitis C with amantadine. Dig Dis Sci 1997; 42: 1681–7.
- Tabone M, Ercole E, Zaffino C, Sallio Bruno F, Pera A, Bonino F. Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients. Ital J Gastroenterol Hepatol 1998; 30: 611–3.
- Fong T-L, Fried MW, Clarke-Platt J. A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy. Am J Gastroenterol 1999; 94: 990–3.
- Knodell RG, Ishak KG, Black WG, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5.
- Okamoto H, Satoyoki K, Tokita H, Inoue T, Woodfield GD, Holland PV, et al. A second generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced form the core. J Virol Methods 1996; 57: 31–45.
- Douglas JR. Prophylaxis and treatment of influenza. N Engl J Med 1990; 322: 443–50.
- Senturk H, Uzunalimoglu O, Batur Y, Mert A, Cetinkaya H, Ersoz G, et al. Long-term efficacy of Interferon-α and Ursodeoxycholic acid in the treatment of chronic type C hepatitis. Dig Dis Sci 1997; 42: 1438–44.